Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Montravers

Showing results (1-10 of 295) with videos related to

Pageof 30
Sort By:
Current Opinion in Infectious Diseases|October 10, 2018
The ideal patient profile for new beta-lactam/beta-lactamase inhibitorsPhilippe Montravers, Matteo Bassetti
International Journal of Antimicrobial Agents|December 14, 2005
Clinical consequences of resistant Candida infections in intensive carePhilippe Montravers, Khalil Jabbour
Current Opinion in Infectious Diseases|December 5, 2020
Cotrimoxazole and clindamycin in skin and soft tissue infectionsPhilippe Montravers, Christian Eckmann
Current Infectious Disease Reports|December 20, 2008
Pharmacokinetics of antibiotics or antifungal drugs in intensive care unitsGuillaume Dufour, Philippe Montravers
Transplantation|December 8, 2022
Commentary on "Lung Transplantation for COVID-19 Pulmonary Sequelae": Beautiful Story, Already History?Nathalie Zappella, Philippe Montravers
Current Opinion in Infectious Diseases|December 5, 2020
Current management of necrotizing soft-tissue infectionsChristian Eckmann, Philippe Montravers
La Revue Du Praticien|March 14, 2023
[Therapeutic implications of the microbiology of severe skin infections]Sébastien Tanaka, Philippe Montravers
European Journal of Anaesthesiology|March 4, 2021
Can we learn from others? The Swedish intensive care unit database for COVID-19 casesPhilippe Montravers, Aurelie Gouel-Cheron
Journal of Critical Care|May 4, 2019
Source control and intra-abdominal infections: Still many questions and only limited answersPhilippe Montravers, Ignacio Martin-Loeches
Current Infectious Disease Reports|July 28, 2011
When and how to cover for fungal infections in patients with severe sepsis and septic shockNicolas Allou, Jerome Allyn, Philippe Montravers
Pageof 30

Showing results (1-10 of 295) with videos related to

Sort By:
Pageof 30
Current Opinion in Infectious Diseases|October 10, 2018
The ideal patient profile for new beta-lactam/beta-lactamase inhibitorsPhilippe Montravers, Matteo Bassetti
International Journal of Antimicrobial Agents|December 14, 2005
Clinical consequences of resistant Candida infections in intensive carePhilippe Montravers, Khalil Jabbour
Current Opinion in Infectious Diseases|December 5, 2020
Cotrimoxazole and clindamycin in skin and soft tissue infectionsPhilippe Montravers, Christian Eckmann
Current Infectious Disease Reports|December 20, 2008
Pharmacokinetics of antibiotics or antifungal drugs in intensive care unitsGuillaume Dufour, Philippe Montravers
Transplantation|December 8, 2022
Commentary on "Lung Transplantation for COVID-19 Pulmonary Sequelae": Beautiful Story, Already History?Nathalie Zappella, Philippe Montravers
Current Opinion in Infectious Diseases|December 5, 2020
Current management of necrotizing soft-tissue infectionsChristian Eckmann, Philippe Montravers
La Revue Du Praticien|March 14, 2023
[Therapeutic implications of the microbiology of severe skin infections]Sébastien Tanaka, Philippe Montravers
European Journal of Anaesthesiology|March 4, 2021
Can we learn from others? The Swedish intensive care unit database for COVID-19 casesPhilippe Montravers, Aurelie Gouel-Cheron
Journal of Critical Care|May 4, 2019
Source control and intra-abdominal infections: Still many questions and only limited answersPhilippe Montravers, Ignacio Martin-Loeches
Current Infectious Disease Reports|July 28, 2011
When and how to cover for fungal infections in patients with severe sepsis and septic shockNicolas Allou, Jerome Allyn, Philippe Montravers
Pageof 30